Nobiletin promotes osteogenic differentiation of human osteoblastic cell line (MG-63)‎ through activating the BMP-2-RUNX-2 signaling pathway

الملخص EN

Nobiletin (NOB) is polymethoxy flavonoids, which plentifully there in Citrus depressa and they demonstrate numerous pharmacological effects.

NOB has an anti-proliferative effect, attenuates ovalbumin-treated eosinophilic airway inflammation and Type II collagen treated arthritis.

NOB noticeably inhibits bone resorption and renovates bone loss in mice model, but role of NOB in bone metabolism is unclear.

Human bone is a important organ that sustains its homeostasis among bone resorpting osteoclasts and bone developing osteoblasts.

The balances of among these two kind of cell outcomes are implicated in bone remodeling.

The current study designed to explore possessions of NOB on differentiation and proliferation of MG-63 cells and contribution of morphogenetic protein signaling.

Cell proliferation was analyzed by MTT, mineralization analysis by alizarin red staining and morphogenetic signaling protein by RT-PCR.

No stimulus outcome of NOB on cell proliferation was found at days of 1, 3 and 7.

Accumulation of calcium was augmented after that treatment of NOB.

The mRNA expression of BMP-2, COL-I, ALP, OCN, RUNX2 and COL1A1 augmented markedly with NOB supplement.

Hence, NOB can stimulate osteogenic differentiation of MG-63, almost certainly by promoting RUNX2 and BMP-2 signaling and this result might provide to its action on stimulation of osteoblast development, differentiation and augments of bone mass.